As an additional immune evasion strategy, tumour cells can also re-wire cGAS-mediated STING signalling towards increased non-canonical NF-κB activation in cancer cells through the NF-κB subunits p52 and RelB [118,140]. The gene discussed is NFKB1; the disease is cancer.